Loading...
 
Toggle Health Problems and D

Vitamin D supplementation reduces many Cardiovascular Disease markers– meta-analysis July 2018

Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.

Front Cardiovasc Med. 2018 Jul 12;5:87. doi: 10.3389/fcvm.2018.00087. eCollection 2018.
Mirhosseini N1, Rainsbury J2, Kimball SM1,3.

Vitamin D Life

Studies in both Vitamin D Life categories Cardiovascular and Meta-analysis:

 Download the PDF from Vitamin D Life

A few of the many wonderful tables
Image
Image
Image

Background: Cardiovascular disease (CVD) risk factors are associated with low serum 25 hydroxyvitamin D (25(OH)D) concentrations in observational studies; however, clinical trial findings are inconsistent.

Objective: We assessed the effect of vitamin D supplementation and increased serum 25(OH)D concentrations on CVD risk factors in a systemic review and meta-analysis of randomized controlled trials (RCTs).

Design: MEDLINE, CINAHL, EMBASE, and Google Scholar were searched for RCTs that evaluated vitamin D supplementation and cardiovascular outcomes [blood pressure, parathyroid hormone (PTH), serum high-sensitivity C-reactive protein (hs-CRP), total cholesterol, high and low density lipoprotein (HDL and LDL, respectively), triglycerides, peak wave velocity (PWV) and Augmentation Index (AI)] from 1992 through 2017. Meta-analysis was based on a random-effects model and inverse variance method to calculate standardized mean difference (SMD) as effect sizes, followed by a leave-one-out method for sensitivity analysis. Risk of publication bias was assessed using Cochrane checklist and Begg funnel plots. The systematic review is registered as CRD42015025346.

Results: We identified 2341 studies from which 81 met inclusion criteria. The meta-analysis indicated a significant reduction in

  • systolic blood pressure (SMD = -0.102 ± 0.04 mmHg, 95% confidence interval (CI), -0.20 to -0.03),
  • diastolic blood pressure (SMD = -0.07 ± 0.03 mmHg, 95% CI, -0.14 to -0.006),
  • serum PTH (SMD = -0.66 ± 0.08 ng/L, 95% CI, -0.82 to -0.49),
  • hs-CRP (SMD = -0.20 ± 0.07 mg/L, 95% CI, -0.34 to -0.06),
  • total cholesterol (SMD = -0.15 ± 0.06 mmol/L, 95% CI, -0.25 to -0.04),
  • LDL (SMD = -0.10 ± 0.05 mmol/L, 95% CI, -0.20 to -0.003),
  • triglycerides (SMD = -0.12 ± 0.06 mmol/L, 95% CI, -0.23 to -0.003) and a significant increase in
  • HDL (SMD = 0.09 ± 0.04 mmol/L, 95% CI, 0.00 to 0.17)

with vitamin D supplementation. These findings remained significant in sensitivity analyses for blood pressure, lipid profile, serum PTH, and serum hs-CRP. There was no significant effect of vitamin D supplementation on PWV (SMD = -0.20 ± 0.13 m/s, 95% CI, -0.46 to 0.06, p = 0.14) and AI (SMD = -0.09 ± 0.14%, 95% CI, -0.37 to 0.19, p = 0.52) for vitamin D supplemented groups.

Conclusion: These findings suggest that vitamin D supplementation may act to protect against CVD through improving risk factors, including high blood pressure, elevated PTH, dyslipidemia, and inflammation.


Created by admin. Last Modification: Thursday June 20, 2019 19:35:11 GMT-0000 by admin. (Version 4)

Attached files

ID Name Comment Uploaded Size Downloads
12178 CV meta1.jpg admin 20 Jun, 2019 145.38 Kb 582
12177 CV meta3.jpg admin 20 Jun, 2019 130.29 Kb 501
12176 CV meta2.jpg admin 20 Jun, 2019 61.37 Kb 504
12174 CV meta 2018.pdf admin 20 Jun, 2019 1.31 Mb 407